Oscar Health, Inc. (NYSE:OSCR) Receives $26.22 Consensus Price Target from Brokerages

Shares of Oscar Health, Inc. (NYSE:OSCR) have been assigned an average rating of “Hold” from the twelve ratings firms that are covering the company, Marketbeat.com reports. Eight equities research analysts have rated the stock with a hold recommendation, three have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $26.2222.

Several research analysts have weighed in on the stock. Robert W. Baird set a $27.00 target price on shares of Oscar Health in a research report on Friday, August 7th. Zacks Research upgraded shares of Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 6th. Wells Fargo & Company boosted their price target on Oscar Health from $20.00 to $27.00 and gave the stock an “equal weight” rating in a research note on Thursday, August 13th. Piper Sandler reissued an “overweight” rating and set a $36.00 price target on shares of Oscar Health in a research note on Tuesday, July 28th. Finally, Weiss Ratings upgraded Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a report on Tuesday, August 11th.

Oscar Health Price Performance

Shares of NYSE OSCR opened at $32.20 on Friday. The firm has a market capitalization of $9.94 billion, a P/E ratio of 23.00, a PEG ratio of 0.66 and a beta of 2.37. Oscar Health has a one year low of $10.69 and a one year high of $33.55. The company’s fifty day moving average is $30.43 and its two-hundred day moving average is $22.74. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.70. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The business had revenue of $4.88 billion during the quarter, compared to the consensus estimate of $4.73 billion. During the same quarter last year, the firm posted ($0.89) EPS. The business’s revenue was up 70.4% compared to the same quarter last year. Analysts forecast that Oscar Health will post 1.54 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CFO Richard Blackley sold 18,750 shares of Oscar Health stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $31.74, for a total transaction of $595,125.00. Following the completion of the transaction, the chief financial officer owned 56,250 shares of the company’s stock, valued at $1,785,375. The trade was a 25.00% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Mark T. Bertolini sold 624,244 shares of the business’s stock in a transaction dated Tuesday, June 30th. The stock was sold at an average price of $28.48, for a total transaction of $17,778,469.12. Following the completion of the sale, the chief executive officer owned 7,751,570 shares in the company, valued at $220,764,713.60. This represents a 7.45% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders have sold 4,241,556 shares of company stock worth $124,280,299. 22.64% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Oscar Health

Hedge funds have recently added to or reduced their stakes in the business. Jones Financial Companies Lllp lifted its holdings in shares of Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after purchasing an additional 2,242 shares in the last quarter. Strs Ohio purchased a new position in shares of Oscar Health during the 1st quarter worth approximately $30,000. Fifth Third Bancorp raised its position in shares of Oscar Health by 148.7% during the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock worth $34,000 after purchasing an additional 1,413 shares during the last quarter. CoreCap Advisors LLC lifted its stake in Oscar Health by 526.3% in the 2nd quarter. CoreCap Advisors LLC now owns 1,190 shares of the company’s stock valued at $34,000 after buying an additional 1,000 shares in the last quarter. Finally, Quarry LP lifted its stake in Oscar Health by 439.8% in the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after buying an additional 1,469 shares in the last quarter. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.